Abstract:Significance: Reactive oxygen species (ROS) are generated during mitochondrial oxidative metabolism, and are tightly controlled through homeostatic mechanisms to maintain intracellular redox, regulating growth and proliferation in healthy cells. However, ROS production is perturbed in cancers where abnormal accumulation of ROS leads to oxidative stress and genomic instability, triggering oncogenic signaling pathways on one hand, while increasing oxidative damage and triggering ROS-dependent death signaling on the other. Recent Advances: Our review illuminates how critical interactions between ROS and oncogenic signaling, the tumor microenvironment, and DNA damage response (DDR) pathways have led to interest in ROS modulation as a means of enhancing existing anticancer strategies and developing new therapeutic opportunities. Critical Issues: ROS equilibrium exists via a delicate balance of pro-oxidant and antioxidant species within cells. "Antioxidant" approaches have been explored mainly in the form of chemoprevention, but there is insufficient evidence to advocate its routine application. More progress has been made via the "pro-oxidant" approach of targeting cancer vulnerabilities and inducing oxidative stress. Various therapeutic modalities have employed this approach, including direct ROS-inducing agents, chemotherapy, targeted therapies, DDR therapies, radiotherapy, and immunotherapy. Finally, emerging delivery systems such as "nanosensitizers" as radiotherapy enhancers are currently in development. Future Directions: While approaches designed to induce ROS have shown considerable promise in selectively targeting cancer cells and dealing with resistance to conventional therapies, most are still in early phases of development and challenges remain. Further research should endeavor to refine treatment strategies, optimize drug combinations, and identify predictive biomarkers of ROS-based cancer therapies.

The Role of Redox Environment in Tumors

Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis

Redox regulation of microRNAs in cancer.

The double-edged roles of ROS in cancer prevention and therapy

Cross-Regulation Between Redox and Epigenetic Systems in Tumorigenesis: Molecular Mechanisms and Clinical Applications

Redox Dysregulation in the Tumor Microenvironment Contributes to Cancer Metastasis.

Redox regulation and its emerging roles in cancer treatment

Does each Component of Reactive Oxygen Species have a Dual Role in the Tumor Microenvironment?

Mitochondrial Redox Signaling And Tumor Progression

[A Review of the Redox Regulation of Tumor Metabolism].

Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment

Redox Regulation in Tumor Cell Epithelial–mesenchymal Transition: Molecular Basis and Therapeutic Strategy

Redox Signaling-Mediated Tumor Extracellular Matrix Remodeling: Pleiotropic Regulatory Mechanisms.

Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development

Redox Regulation of Cell Survival

Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy

Redox regulation of cancer metastasis: molecular signaling and therapeutic opportunities.

The role of reactive oxygen species in tumor treatment

Targeting ROS in cancer: rationale and strategies

The role of ROS in tumour development and progression

Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies